Ligand Pharmaceuticals (LGND)
(Delayed Data from NSDQ)
$104.30 USD
-4.69 (-4.30%)
Updated Aug 1, 2024 04:00 PM ET
After-Market: $104.41 +0.11 (0.11%) 4:24 PM ET
NA Value
NA Growth NA Momentum NA VGMKey Expected Earnings Data
Report Date | Period Ending | Zacks Consensus Estimate | Earnings ESP |
---|---|---|---|
08/06/2024
Time: AMC |
6/2024 | $1.10 | 0.00% |
Earnings Summary
For their last quarter, Ligand Pharmaceuticals (LGND) reported earnings of $1.20 per share, beating the Zacks Consensus Estimate of $1.13 per share. This reflects a positive earnings surprise of 6.19%. Look out for LGND's next earnings release on August 06, 2024. For the next earning release, we expect the company to report earnings of $1.10 per share, reflecting a year-over-year decrease of 22.54%.
Earnings History
Price & Consensus
Zacks News for LGND
Gilead (GILD) Up as Twice-Yearly HIV Shot Prevents Infection
LGND: What are Zacks experts saying now?
Zacks Private Portfolio Services